The Regulatory team at JensonR+ have been reviewing the changes in MHRA guidance on this topic since the end of the UK-EU transition period. They have captured the key changes and actions that need to be taken in a helpful video
The Regulatory team at JensonR+ have been considering the changes to European MR/DC Procedures for medicines following the end of transition period and offer some guidance in this helpful video
Medicines Management in Professional Sport One aspect of taking the plunge and being a freelance regulatory consultant, is the opportunity to explore new ideas and concepts. Especially when you decide to decide to run 3 networking events a year and need to embrace and use all of your networking skills repeatedly. I am pleased [...]
CBD and the latest developments. Our last Special interest Group (SIG) of the year is all about Cannabidiol (CBD). Its been an explosive new kid on the block. Within the space of a couple of years, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and [...]
Consumer Protection. At the moment people are looking towards the restarting of schools, the winter season and wondering how to protect themselves. How to do all that they can to stay healthy and well. Its natural that they may consider supplementation to their diet (as part of a varied diet and healthy lifestyle). Its worth [...]
Join us JensonR+ are a leading consultancy providing a wide range of regulatory support to life science businesses with a focus on UK and Republic of Ireland markets. Due to continued growth, we are looking to recruit life science graduates to join our specialist teams in our Barnstaple, Devon and Nottingham offices. This opportunity [...]
JensonR+ are a leading consultancy providing a wide range of regulatory support to life science businesses with a focus on UK and Republic of Ireland markets. Due to continued growth, we are looking to recruit life science graduates to join our specialist teams in our Barnstaple, Devon and Nottingham offices. This opportunity will allow you [...]
The Association of British Pharmaceutical Industry (ABPI) and The Prescription Medicines Code of Practice Authority (PMCPA)* have launched a consultation for the proposed changes for the 2021 Code of Practice. The changes are designed to bring the ABPI Code up-to-date and reflect the recent updates made to the 2019 EFPIA Code.